BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 28056488)

  • 41. Targeting human secretory phospholipase A2 with designed peptide inhibitors for inflammatory therapy.
    Wang P; Li Y; Shao Q; Zhou W; Wang K
    J Drug Target; 2015 Feb; 23(2):140-6. PubMed ID: 25237841
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Structural basis of the significant calmodulin-induced increase in the enzymatic activity of secreted phospholipases A(2).
    Kovacic L; Novinec M; Petan T; Krizaj I
    Protein Eng Des Sel; 2010 Jun; 23(6):479-87. PubMed ID: 20348188
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Conservation analysis and decomposition of residue correlation networks in the phospholipase A2 superfamily (PLA2s): Insights into the structure-function relationships of snake venom toxins.
    Oliveira A; Bleicher L; Schrago CG; Silva Junior FP
    Toxicon; 2018 May; 146():50-60. PubMed ID: 29608922
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The atypical binding mechanism of second calcium on phospholipase A2 group IIE.
    Hou S; Bai J; Chen C; Zhang X; Chang F; Cao Z; Xu T; Xie J
    Biochem Biophys Res Commun; 2021 Jun; 557():267-272. PubMed ID: 33894413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MVL-PLA2, a phospholipase A2 from Macrovipera lebetina transmediterranea venom, inhibits tumor cells adhesion and migration.
    Bazaa A; Luis J; Srairi-Abid N; Kallech-Ziri O; Kessentini-Zouari R; Defilles C; Lissitzky JC; El Ayeb M; Marrakchi N
    Matrix Biol; 2009 May; 28(4):188-93. PubMed ID: 19351557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. β-keto amyrin isolated from Cryptostegia grandiflora R. br. inhibits inflammation caused by Daboia russellii viper venom: Direct binding of β-keto amyrin to phospholipase A
    Santhosh KH; Krishna V; Kemparaju K; Manjunatha H; Shashi Kumar R; Mukherjee A; Gomez Mejiba SE; Ramirez DC; Ravindranath BS
    Toxicon; 2024 Apr; 241():107679. PubMed ID: 38447765
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biochemical characterization of selective inhibitors of human group IIA secreted phospholipase A(2) and hyaluronic acid-linked inhibitor conjugates.
    Oslund RC; Gelb MH
    Biochemistry; 2012 Oct; 51(43):8617-26. PubMed ID: 23020658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Unusual mode of binding of human group IIA secreted phospholipase A2 to anionic interfaces as studied by continuous wave and time domain electron paramagnetic resonance spectroscopy.
    Canaan S; Nielsen R; Ghomashchi F; Robinson BH; Gelb MH
    J Biol Chem; 2002 Aug; 277(34):30984-90. PubMed ID: 12039961
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification, description and structural analysis of beta phospholipase A
    Fortes-Dias CL; Fernandes CAH; Ortolani PL; Campos PC; Melo LA; Felicori LF; Fontes MRM
    Toxicon X; 2019 Apr; 2():100009. PubMed ID: 32550566
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Design and Amberlyst-15 mediated synthesis of novel thienyl-pyrazole carboxamides that potently inhibit Phospholipase A2 by binding to an allosteric site on the enzyme.
    Kumar AD; Prabhudeva MG; Bharath S; Kumara K; Lokanath NK; Kumar KA
    Bioorg Chem; 2018 Oct; 80():444-452. PubMed ID: 29986189
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Simultaneous inhibition of anti-coagulation and inflammation: crystal structure of phospholipase A2 complexed with indomethacin at 1.4 A resolution reveals the presence of the new common ligand-binding site.
    Singh N; Kumar RP; Kumar S; Sharma S; Mir R; Kaur P; Srinivasan A; Singh TP
    J Mol Recognit; 2009; 22(6):437-45. PubMed ID: 19462410
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Modeling studies on phospholipase A2-inhibitor complexes.
    Nirmal N; Praba GO; Velmurugan D
    Indian J Biochem Biophys; 2008 Aug; 45(4):256-62. PubMed ID: 18788476
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Viper Venom Phospholipase A2 Database: The Structural and Functional Anatomy of a Primary Toxin in Envenomation.
    de Oliveira ALN; Lacerda MT; Ramos MJ; Fernandes PA
    Toxins (Basel); 2024 Feb; 16(2):. PubMed ID: 38393149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Revealing the functional structure of a new PLA2 K49 from Bothriopsis taeniata snake venom employing automatic "de novo" sequencing using CID/HCD/ETD MS/MS analyses.
    Carregari VC; Dai J; Verano-Braga T; Rocha T; Ponce-Soto LA; Marangoni S; Roepstorff P
    J Proteomics; 2016 Jan; 131():131-139. PubMed ID: 26481240
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structural and pharmacological features of phospholipases A2 from snake venoms.
    de Paula RC; Castro HC; Rodrigues CR; Melo PA; Fuly AL
    Protein Pept Lett; 2009; 16(8):899-907. PubMed ID: 19689416
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of Potent and Selective Inhibitors for Group VIA Calcium-Independent Phospholipase A2 Guided by Molecular Dynamics and Structure-Activity Relationships.
    Mouchlis VD; Limnios D; Kokotou MG; Barbayianni E; Kokotos G; McCammon JA; Dennis EA
    J Med Chem; 2016 May; 59(9):4403-14. PubMed ID: 27087127
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular Characterization of Three Novel Phospholipase A₂ Proteins from the Venom of Atheris chlorechis, Atheris nitschei and Atheris squamigera.
    Wang H; Chen X; Zhou M; Wang L; Chen T; Shaw C
    Toxins (Basel); 2016 Jun; 8(6):. PubMed ID: 27258312
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Crystal structure of a complex formed between a snake venom phospholipase A(2) and a potent peptide inhibitor Phe-Leu-Ser-Tyr-Lys at 1.8 A resolution.
    Chandra V; Jasti J; Kaur P; Dey S; Perbandt M; Srinivasan A; Betzel Ch; Singh TP
    J Biol Chem; 2002 Oct; 277(43):41079-85. PubMed ID: 12186870
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Native peptide inhibition. Specific inhibition of type II phospholipases A2 by synthetic peptides derived from the primary sequence.
    Tseng A; Inglis AS; Scott KF
    J Biol Chem; 1996 Sep; 271(39):23992-8. PubMed ID: 8798633
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Arachidonic acid release from mammalian cells transfected with human groups IIA and X secreted phospholipase A(2) occurs predominantly during the secretory process and with the involvement of cytosolic phospholipase A(2)-alpha.
    Mounier CM; Ghomashchi F; Lindsay MR; James S; Singer AG; Parton RG; Gelb MH
    J Biol Chem; 2004 Jun; 279(24):25024-38. PubMed ID: 15007070
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.